NCT02531178View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

ABBV-257

subcutaneous injection

BIOLOGICAL

Placebo

Placebo for ABBV-257

Trial Locations (1)

10117

Site Reference ID/Investigator# 139394, Berlin

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY